Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

All GLG News Analyses Filed Under: Business of Medicine

Articles with lock require a GLG News subscription
Posted May 22, 2008
China Muscles In On The Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
Any finished medication that a Chinese company tries to bring to the US (or European) market will face tremendous scrutiny.  Look for Indian generic manufacturers (e.g. Ranbaxy, Dr Reddy's) to maintain their competitive edge due to their track record of safety.  Eventually, lower cost generics...
John Ansell Posted May 21, 2008
Chinese generics is nothing new
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: John Ansell, Director John Ansell Consultancy
In 1976, sitting in my office in International Marketing at Fisons, Loughborough, UK, I used to watch the drums of bulk paracetamol arriving at the factory from China - easily recognizable from the Chinese script decorating them. I'm sure the UK wasn't the only country importing raw materials from China...
Posted May 21, 2008
China Muscles In On The Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
Until Chinese regulations and enforcement catch up with Western consumer standards, the market for Chinese pharmaceuticals will be greatly diminished by its reputation.
Posted May 20, 2008
Warning over drug trial’s effects on testing
Analysis of: Warning over drug trial’s effects on testing | www.ft.com
Author: GLG Member Program Contributor
1. Goverment, insurers and other payors will undermine investment in new indications if it saves money. 2. Their next direction will be to fund biogeneric and other innovator altneratives. 3. Companies developing high value line extensions must consider formulation management and other strategies...
Posted May 20, 2008
China Muscles In On The Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
Low cost generics to be produced in China will lower drug costs.
Posted May 20, 2008
Warning over drug trial’s effects on testing
Analysis of: Warning over drug trial’s effects on testing | www.ft.com
Author: GLG Member Program Contributor
For too long big pharma has dictated which drugs will come to market and what they will cost.  The entire American healthcare system is literally collapsing because of two costs:  medications and bureacracy.  Expect more payers to look for ways to bring down costs in the fu...
Posted May 19, 2008
Warning over drug trial’s effects on testing
Analysis of: Warning over drug trial’s effects on testing | www.ft.com
Author: GLG Member Program Contributor
This article warns against "taking testing out of the hands of companies" and warns against the idea that a drug is receiving a Phase 3 trial without early phase testing.  The CATT trial certainly marks a huge change in drug development but what the pharma industry is not appreciating...
Posted May 19, 2008
China Muscles In On The Generics Industry
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
GMP Compliance QC/QA/Validation Facility Engineering and Construction Capabilities
Brian Abbott Posted May 19, 2008
National healthcare? Better find a new pool of physicians
Analysis of: Look to England's example for ways to solve America's health-care problem | www.sltrib.com
Author: Brian Abbott, Medical Director of Hematology Big Sky Oncology
National healthcare has again become part of the presidential election dialog, after a curious 12+ year absence. Also curious, Hillary Clinton is again center stage in the discussion. Will the outcome be different this time?
Brian Abbott Posted May 19, 2008
Medicare: heading toward a crisis
Analysis of: Loss of Doctors Leaves Patients Waiting | www.redorbit.com
Author: Brian Abbott, Medical Director of Hematology Big Sky Oncology
The aging population, coupled with per capita decreases in Medicare spending, threatens the entire health care system. Here's why.
Previous Page : 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next131 to 140 of 573

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-08-29T09:45:18.400